TAK
Takeda Pharmaceutical Co Ltd
17.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.1% | 13.2% | 26.5% | 14.1% | 23.9% | 33.5% | 21.1% | 19.5% | 34.0% | 30.8% | 6.7% | 10.5% | 20.5% | |
| 17.5% | 16.8% | 17.8% | 15.9% | 16.4% | 16.3% | 18.0% | 16.4% | 16.6% | 15.7% | 14.7% | 13.4% | 15.1% | |
| 1.8% | 1.7% | 1.7% | 1.3% | 1.8% | 1.6% | 1.7% | 1.5% | 1.7% | 1.5% | 1.8% | 1.5% | 1.6% | |
| -0.5% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.2% | -14.9% | 5.7% | -6.6% | -6.0% | 7.8% | 0.3% | -3.0% | 2.0% | -3.2% | 22.5% | -13.0% | 1.6% | |
| 6.7% | 6.9% | 6.1% | 12.7% | 7.9% | 5.0% | 8.8% | 6.8% | 4.7% | 18.3% | 5.8% | 4.4% | 8.4% | |
| -31.4% | -6.8% | -5.9% | -13.0% | -6.4% | -10.1% | -1.9% | -3.0% | -4.3% | -18.9% | -5.2% | -7.2% | -9.1% | |
| 0.9% | 12.4% | 0.9% | 11.4% | 0.8% | 12.7% | 0.9% | 13.1% | 0.8% | 12.3% | 0.8% | 12.3% | 6.8% | |
| -0.2% | 0.0% | -0.2% | -0.2% | -0.2% | -0.2% | -4.7% | -4.7% | 0.0% | 0.1% | 0.1% | -0.1% | 0.0% | |
| -15.1% | – | – | – | -5.9% | -41.2% | -19.3% | 0.0% | 3.3% | -0.8% | -2.3% | – | – | |
| -13.5% | -8.8% | -5.5% | 26.2% | -9.4% | -57.3% | -28.6% | -19.4% | -1.1% | -15.9% | -7.0% | -14.8% | -9.9% | |
| 0.2% | -2.7% | 16.1% | 28.7% | 4.6% | -31.9% | -10.3% | -3.2% | 29.8% | -2.2% | -5.4% | -11.0% | 2.4% | |
| 12.4% | 6.2% | 20.4% | 1.4% | 16.0% | 28.6% | 12.3% | 12.7% | 29.2% | 12.4% | 0.9% | 6.1% | 12.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.